Primer: Budweiser Brewing APAC (1876 HK) - Sep 2025
Leadership in Premiumization: Budweiser APAC is strategically positioned to capitalize on the long-term premiumization trend in the Asian beer...
79 Views
Budweiser APAC (1876 HK): Weak 2Q2024. Premium Beer, Cheap Valuations
Worst could be past - expect a likely recovery in China premium beer market in 2H2024 and ongoing commodity tail winds to uplift company's...
387 Views
Bud APAC (1876 HK): Nursing a Hangover; Now Comes a Passive Overhang
Bud APAC is up since the Insight was published and is near the upper end of the downward sloping channel. With Hong Kong closed Monday and Tuesday...
1.3k Views
2024 High Conviction - Giant Biogene - Growth Rate Keeps Moving Higher
Giant Biogene was listed in Hong Kong IPO in 2022. It has done well since and is now trading 45% above its IPO price, but its still cheap.
754 Views
Budweiser APAC: Chinese Beer Makers Poised for a Breakout
The Asia Pacific beer industry, boosted by tourism, may drive a breakout for Budweiser APAC, whose shares are near all-time lows.
636 Views